海特生物(300683.SZ)：第三季度净亏损1.19亿

Core Viewpoint - Hite Bio's Q3 2025 report shows a significant decline in revenue and net profit, indicating potential challenges for the company moving forward [1] Financial Performance - The company's operating revenue for Q3 2025 was 147 million, representing a year-on-year decrease of 11.74% [1] - The net profit attributable to shareholders was -119 million, indicating a loss [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was -122 million [1]